emerging lymphoma therapies: bispecific antibodies and car t-cells
Published 3 years ago • 114 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
6:23
the benefits of bispecific antibodies over car-t cell therapy in lymphoma
-
1:15
emerging car-t therapies for t-cell lymphoma
-
1:40
current & future outlooks on car-t therapy & bispecific antibodies in follicular lymphoma
-
1:51
investigating resistance mechanisms to bispecific antibodies and car-t in patients with lymphoma
-
5:12
the emerging potential of bispecific antibodies as monotherapy & in combination for b-cell lymphoma
-
5:04
dlbcl and car t cell therapy - kim's lymphoma story
-
38:40
bispecific antibodies in lymphoma: an update
-
6:09
bispecific antibodies | high impact topic (hit)
-
12:15
car-t vs bispecific antibodies for lymphoma
-
1:14
the car t-cell strategy vs bispecific antibodies
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
1:48
novel immunotherapy approaches in lymphoma: car-t cells, bispecifics & sequencing
-
5:15
the promise of immunotherapies in t-cell lymphoma
-
1:56
the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
-
1:42
how to best sequence bispecific antibodies and car-t therapy in multiple myeloma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
2:47
advances in allogeneic car-t therapy in lymphoma
-
2:08
the future of car t-cell therapy in lymphoma
-
8:50
an update of car t-cell therapies in lymphoma
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
2:00
the success story of bispecific and trispecific antibodies